Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:31 PM
Study NCT ID:
NCT00788151
Status:
COMPLETED
Last Update Posted:
2022-04-05
First Post:
2008-11-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09-26
Start Date Type:
ACTUAL
Primary Completion Date:
2010-02-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08-16
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-07
First Submit QC Date:
None
Study First Post Date:
2008-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-24
Results First Submit QC Date:
None
Results First Post Date:
2019-07-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-10
Last Update Post Date:
2022-04-05
Last Update Post Date Type:
ACTUAL